Search clinical trials for: desvenlafaxine SR

Total 556 results

Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral Neuropathy

Diabetic Neuropathy, Painful
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Tolerability and Pharmacokinetics of Desvenlafaxine Succinate SR in Healthy Chinese Male and Females

Healthy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women

Vasomotor Symptoms
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)

Depressive Disorder, Major

United States
Pfizer

Completed

Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women

Vasomotor Symptoms

Canada, United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women

Menopause | Vasomotor System

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive Disorder

Major Depressive Disorder
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder

Depression | Major Depressive Disorder

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder

Depressive Disorder, Major Depressive Disorder

United States
Pfizer

Completed

Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR)

Depression - Major Depressive Disorder

Belgium
Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder

Major Depressive Disorder

United States, Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women

Depressive Disorder | Depression | Depressive Disorder, Major

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women

Depressive Disorder | Depression | Depressive Disorder, Major

Colombia, Mexico, United States, Peru, Chile, Argentina
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics of Venlafaxine Extended-Release (ER) and Desvenlafaxine Succinate Sustained-Release (DVS SR) 50 mg in Healthy Subjects

Healthy

United States
University of Alabama at Birmingham

Not yet recruiting

Effects of Sustained-release Oral Sodium Nitrite on Postoperative Pain and Recovery Following Total Knee Arthroplasty

Pain
G&E Herbal Biotechnology Co., LTD

Completed

Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis (AK)

Actinic Keratosis | Bowen's Disease

Taiwan
Otsuka Pharmaceutical Development & Commercialization...

Completed

Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder

Adult ADHD

United States
Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder

Depressive Disorder, Major

United States
Pfizer

Completed

Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder

Major Depressive Disorder

United States, Germany, Estonia, Finland, Former Serbia and Montenegro, France, Latvia, Lithuania, Poland, Slovakia, South Africa
NYU Langone Health

Terminated

Stress Reduction Intervention for Women With Ischemic Heart Disease

Ischemic Heart Disease

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder

Depressive Disorder, Major

Finland, France, South Africa, Estonia, Croatia, Lithuania, Latvia, Slovakia, Poland, Romania
Stingray Therapeutics

Recruiting

A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors

Advanced / Metastatic Solid Tumor

Australia
Tan Tock Seng Hospital
Nanyang Technological University; Institute for Infocomm Research

Recruiting

Multimodal EEG and NIRS-based BCI With Assistive Soft Robotics for Stroke (MBCI-SR) (MBCI-SR)

Stroke

Singapore
Forest Laboratories

Completed

Safety Study of F2695 SR in Major Depressive Disorder (LVM-MD-04)

Major Depressive Disorder

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects

Depressive Disorder | Depression | Depressive Disorder, Major

United States
Pfizer

Completed

Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)

Bacterial Infections
AVAVA, Inc.

Completed

AVAVA SR-1 Wrinkles and BPL Study

Wrinkle | Benign Pigmented Lesion

United States
Mochida Pharmaceutical Company, Ltd.
Pfizer

Completed

A Study of MD-120 in Patients With Depression

Major Depressive Disorder

Japan
Hospital for Special Surgery, New York

Available

Humanitarian Use of AVANTA Orthopaedics Proximal Interphalangeal Joint

Arthroplasty of the PIP Joint

United States
University of Delaware

Completed

Neuromotor Control During Walking in Children With Cerebral Palsy

Cerebral Palsy

United States
Wyeth is now a wholly owned subsidiary of Pfizer
Solvay Pharmaceuticals

Terminated

Study Evaluating Safety and Tolerability of Ascending Multiple Dose of SLV-313 in Schizophrenia Patients

Healthy
Hospital for Special Surgery, New York

Approved for marketing

Use of Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis, Humanitarian Use Device

Arthroplasty of the MCP Joint

United States
Mayo Clinic

Completed

Topical Agent for Treatment of Red Skin

Rosacea | Bilaterally Symmetric Red Skin on Cheeks

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder

Depressive Disorder | Depression | Major Depressive Disorder
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects

Alzheimer Disease

Germany
Orexigen Therapeutics, Inc

Completed

Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity

Obesity

United States
Seoul National University Hospital
Pfizer; Seoul National University Bundang Hospital; Korea Cancer Center Hospital

Terminated

Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen

Breast Neoplasms | Hot Flashes

Korea, Republic of
G&E Herbal Biotechnology Co., LTD

Completed

Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis

Actinic Keratosis

United States
G&E Herbal Biotechnology Co., LTD

Completed

Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)

Genital Warts | Condylomata Acuminata | Condyloma Acuminata | Venereal Warts

Taiwan
Pfizer

Completed

Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder

Major Depressive Disorder

Canada, United States, Colombia, Croatia, Estonia, Finland, Poland, France, Slovakia, Chile, Latvia, Lithuania, Romania, South Africa
Wyeth is now a wholly owned subsidiary of Pfizer
Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder

Major Depressive Disorder

United States
Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Allysta Pharmaceutical
INC Research Australia Pty Ltd

Terminated

ALY688-SR in Generally Healthy Overweight or Obese Adults

Overweight and Obesity

Australia
Shanghai Jiao Tong University Affiliated Sixth...

Completed

The Efficacy of Glucerna SR in Chinese Drug-naïve Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Eastern Hepatobiliary Surgery Hospital

Unknown

Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma

Hepatocellular Carcinoma With CSPH

China
Shanghai 10th People's Hospital

Completed

Effect of Meal Replacement Beverage(Glucerna) on Body Composition,Lipid Metabolism and Blood Pressure

Obesity
The First Affiliated Hospital with Nanjing Medical...
National University Hospital, Singapore; University of Pennsylvania; General... and other collaborators

Unknown

CPVI Alone Versus. CPVI Plus Electrophysiological Substrate Ablation in the LA During SR for the Treatment of Non-PAF (STABLE-SR_II)

Atrial Fibrillation

China
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause

Hot Flashes | Menopause | Sleep Disorders
Pfizer

Completed

Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD)

Major Depressive Disorder

Search clinical trials for: desvenlafaxine SR

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations